Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Sulforaphane on LPS-Induced Matrix Metalloproteinase-9 (MMP-9) Expression

Sulfolaphane이 lipopolysaccharide (LPS)에 의해 유도된 matrix metalloproteinase-9 (MMP-9) 발현에 미치는 영향

  • Lee, Jung-Tae (Department of Immunology, School of Medicine, Keimyung University) ;
  • Woo, Kyung-Jin (Department of Immunology, School of Medicine, Keimyung University) ;
  • Kwon, Taeg-Kyu (Department of Immunology, School of Medicine, Keimyung University)
  • 이정태 (계명대학교 의과대학 면역학 교실) ;
  • 우경진 (계명대학교 의과대학 면역학 교실) ;
  • 권택규 (계명대학교 의과대학 면역학 교실)
  • Received : 2010.01.05
  • Accepted : 2010.02.22
  • Published : 2010.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Sulforaphane is a naturally occurring member of the iosothiocyanate family, which reveals chemopreventive capacities including anti-cancer, anti-inflammation and inhibition of MMP-9 activities. In this study, we investigated the effect of sulforaphane on the expression of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide (LPS)-induced Raw 264.7 cells. Sulforaphane strikingly suppressed the LPS-induced MMP-9 activity and mRNA expression in a dose-dependent manner. In addition, sulforaphane inhibited not only the LPS-induced MMP-9 promoter activity but also LPS-mediated activator protein-1 (AP-1) and nuclear factor-kB (NF-${\kappa}B$) promoter activity. Transient transfection by MMP-9 constructs, in which specific transcriptional factors were mutagenized, indicated that the effects of LPS and sulforaphane were mediated via AP-1 and NF-${\kappa}B$ response elements. We found that sulforaphane had the ability to suppress LPS-induced invasion in vitro. Taken together, these results demonstrated that sulforaphane effectively suppressed LPS-induced MMP-9 expression via modulation of promoter elements (AP-1 and NF-${\kappa}B$) in MMP-9 transcriptional activation.

Sulforaphane은 십자가화 채소에 존재하는 화합물로 항염증, 항암 및 신생혈관 생성의 억제 효과가 알려짐으로써 최근 많은 연구가 활발히 이루어지고 있으나, LPS에 의한 MMP-9 활성 조절에 대한 연구는 매우 미흡한 편이다. 따라서 본 연구에서 sulforaphane이 LPS 유도에 의한 MMP-9 활성에 미치는 영향에 대해서 조사해 보았다. Raw 264.7 세포에 sulforaphane을 전처리 한 후 LPS를 처리하여 gelatin zymography를 실시해 본 결과, LPS에 의해 유도된 MMP-9 활성 증가가 sulforaphane 농도 의존적으로 감소됨을 확인 하였다. 또한 RT-PCR과 MMP-9의 luciferase assay를 통한 실험에서 sulforaphane의 MMP-9 억제효과가 전사단계에서 조절됨을 추측 할 수 있었다. MMP-9 promoter 부위에 여러 가지의 전사조절인자 결합부위가 존재한다. 특히 AP-1과 NF-${\kappa}B$가 중요 전사조절인자로 작용하여 MMP-9 발현조절에 관여한다. 본 실험에서 sulforaphane에 의한 MMP-9 억제효과 기전에 이들 전사조절인자들의 중요한 역할을 조사하였다. AP-1과 NF-${\kappa}B$ 결합부위를 변형 시킨 vector를 transfection하여 MMP-9의 promoter 활성을 측정한 결과, 정상 vector에 비해 그 활성도가 현저히 떨어짐을 확인하였고, LPS에 의해 증가되는 AP-1과 NF-${\kappa}B$의 basal promoter 활성 또한 sulforaphane에 의해 감소됨을 관찰 할 수 있었다. 이상의 결과에서 sulforaphane의 MMP-9 활성억제효과는 AP-1과 NF-${\kappa}B$와 같은 전사인자들이 MMP-9의 전사를 조절함으로써 일어나는 것임을 알 수 있었다. 그리고 sulforaphane은 세포의 invasion능력 또한 효과적으로 억제시킴을 관찰 할 수 있었는데 이는 MMP-9 활성억제효과와 밀접한 관련이 있음을 추측 할 수 있었다.

Keywords

References

  1. Annabi, B., S. Rojas-Sutterlin, M. Laroche, M. P. Lachambre, R. Moumdjian, and R. Beliveau. 2008. The diet-derived sulforaphane inhibits matrix metalloproteinase-9-activated human brain microvascular endothelial cell migration and tubulogenesis. Mol. Nutr. Food Res. 52, 692-700. https://doi.org/10.1002/mnfr.200700434
  2. Asakage, M., N. H. Tsuno, J. Kitayama, T. Tsuchiya, S. Yoneyama, J. Yamada, Y. Okaji, S. Kaisaki, T. Osada, K. Takahashi, and H. Nagawa. 2006. Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis 9, 83-91. https://doi.org/10.1007/s10456-006-9034-0
  3. Basset, P., A. Okada, M. P. Chenard, R. Kannan, I. Stoll, P. Anglard, J. P. Bellocq, and M. C. Rio. 1997. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol. 15, 535-541. https://doi.org/10.1016/S0945-053X(97)90028-7
  4. Brooks, J. D., V. G. Paton, and G. Vidanes. 2001. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol. Biomarkers Prev. 10, 949-954.
  5. Gum, R., H. Wang, E. Lengyel, J. Juarez, and D. Boyd. 1997. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481-1493. https://doi.org/10.1038/sj.onc.1200973
  6. Juge, N., R. F. Mithen, and M. Traka. 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol. Life Sci. 64, 1105-1127. https://doi.org/10.1007/s00018-007-6484-5
  7. Kerkela, E, and U. Saarialho-Kere. 2003. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp. Dermatol. 12, 109-125. https://doi.org/10.1034/j.1600-0625.2003.120201.x
  8. Lee, P. P., J. J. Hwang, G. Murphy, and M. M. Ip. 2000. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology 141, 3764-3773. https://doi.org/10.1210/en.141.10.3764
  9. Nelson, A. R., B. Fingleton, M. L. Rothenberg, and L. M. Matrisian. 2000. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18, 1135-1149.
  10. Rose, P., Q. Huang, C. N. Ong, and M. Whiteman. 2005. Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells. Toxicol. Appl. Pharmacol. 209, 105-113. https://doi.org/10.1016/j.taap.2005.04.010
  11. Roy, R., J. Yang, and M. A. Moses. 2009. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287-5297. https://doi.org/10.1200/JCO.2009.23.5556
  12. Sato, H. and M. Seiki. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405.
  13. Sato, H., M. Kita, and M. Seiki. 1993. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268, 23460-23468.
  14. Simon, C., H. Goepfert, and D. Boyd. 1998. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58, 1135-1139.
  15. Stetler-Stevenson, W. G. and A. E. Yu. 2001. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 11, 143-152. https://doi.org/10.1006/scbi.2000.0365
  16. Thejass, P. and G. Kuttan. 2006. Antimetastatic activity of Sulforaphane. Life Sci. 78, 3043-3050. https://doi.org/10.1016/j.lfs.2005.12.038
  17. Woo, J. H., J. H. Lim, Y. H. Kim, S. I. Suh, D. S. Min, J. S. Chang, Y. H. Lee, J. W. Park, and T. K. Kwon. 2004. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23, 1845-1853. https://doi.org/10.1038/sj.onc.1207307
  18. Woo, J. H., J. W. Park, S. H. Lee, Y. H. Kim, I. K. Lee, E. Gabrielson, S. H. Lee, H. J. Lee, Y. H. Kho, and T. K. Kwon. 2003. Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Res. 63, 3430-3434.